Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
164,052,981
-
Total 13F shares
-
36,353,167
-
Share change
-
+36,353,167
-
Total reported value
-
$512,042,809
-
Price per share
-
$14.11
-
Number of holders
-
38
-
Value change
-
+$512,042,809
-
Number of buys
-
38
Institutional Holders of Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) as of Q3 2023
As of 30 Sep 2023,
Neumora Therapeutics, Inc. - Common Stock, $0.0001 par value (NMRA) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,353,167 shares.
The largest 10 holders included
SOFTBANK GROUP CORP., FMR LLC, MIC Capital Management UK LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, Artal Group S.A., CITADEL ADVISORS LLC, EcoR1 Capital, LLC, Avidity Partners Management LP, HHLR ADVISORS, LTD., and ORBIMED ADVISORS LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.